CytomX Therapeutics, Inc. (CTMX)
4.24
-0.01
(-0.24%)
USD |
NASDAQ |
Apr 09, 16:00
4.26
+0.02
(+0.47%)
After-Hours: 04:39
CytomX Therapeutics EPS Diluted (Quarterly) : -0.1734 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
| REGENXBIO, Inc. | -1.298 |
| Ovid Therapeutics, Inc. | 0.1183 |
| Olema Pharmaceuticals, Inc. | -0.5044 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.51M |
| Revenue (Quarterly) | 0.663M |
| Total Expenses (Quarterly) | 27.17M |
| Enterprise Value | 783.78M |
| Gross Profit Margin (Quarterly) | 23.08% |
| Profit Margin (Quarterly) | -4.00K% |
| Earnings Yield | 0.22% |
| Normalized Earnings Yield | 0.2067 |